28.8 C
Vientiane
Sunday, September 21, 2025
spot_img

Cision PR Newswire

Sasken Partners with VicOne to Deliver End-to-End Automotive Cybersecurity Solutions

BENGALURU, India, Sept. 21, 2025 /PRNewswire/ -- Sasken Technologies Limited, a leader in product engineering and digital transformation, today announced its strategic partnership with VicOne, an...

LISEN’s Four Power Banks Deliver New Multi-Scenario Charging Experiences for iPhone 17 Series

NEW YORK, Sept. 20, 2025 /PRNewswire/ -- The iPhone 17 Series has launched officially,...

Nanjing Jiangbei New Area Issues Global Call for Talents

NANJING, China, Sept. 20, 2025 /PRNewswire/ -- On September 20, Nobel laureates, academicians, young...

China-ASEAN AI Application Ecosystem Exchange Conference 2025 Kicks Off in Nanning

NANNING, China, Sept. 20, 2025 /PRNewswire/ -- A report from CCTV.com:  The China...

Intelligence Connects All, AI Empowers the Future: 2025 China International Consumer Electronics Exposition Opens in Qingdao

QINGDAO, China, Sept. 20, 2025 /PRNewswire/ -- The 2025 China International Consumer Electronics Exposition (CICE)...

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced...

SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast...

SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025

BEIJING, June 3, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day...

XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson’s Diseases, Spinal Cord Injury and...

SUZHOU, China, June 3, 2025 /PRNewswire/ -- XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived...